Smith & Nephew (SN.)

Sector:

Health Care

Index:

FTSE 100

1,236.00p
   
  • Change Today:
    -9.00p
  • 52 Week High: 1,435.00p
  • 52 Week Low: 937.80p
  • Currency: UK Pounds
  • Shares Issued: 848.71m
  • Volume: 226,978
  • Market Cap: £10,490m
  • RiskGrade: 173

Director dealings: Smith & Nephew board members invest, Galliford Try CFO covers tax bill

By Josh White

Date: Friday 07 Nov 2025

LONDON (ShareCast) - (Sharecast News) - Smith & Nephew and Galliford Try both disclosed share dealings involving senior management and board associates on Friday.
At Smith & Nephew, chief corporate strategy and development officer Ajay Dhankhar purchased 18,460 American depositary shares in the medical technology group at $32.58 each, for a total consideration of roughly $602,000.

In a separate transaction, Kagama Family Investments LP, an entity linked to independent non-executive director Garheng Kong, acquired 3,000 shares at $33.98 apiece, worth just over $100,000.

Both transactions took place on 6 November on the New York Stock Exchange.

The purchases followed a steep share price decline this week after Smith & Nephew reported third-quarter revenue of $1.5bn, missing analyst estimates of $1.51bn due to weaker US knee implant sales.

Shares in the London-listed group fell nearly 9% on Thursday after the update, raising concerns about demand trends in key surgical markets despite solid growth in other product lines.

Meanwhile, Galliford Try said its chief financial officer Kris Hampson was issued 9,518 ordinary shares on 5 November under a buy-out award compensating for incentives forfeited at his previous employer.

He later sold 4,474 shares at 376.7p each to cover tax liabilities, with the shares repurchased by the company's employee benefit trust.

The dealings came as analyst sentiment around Galliford Try remained steady, with a consensus price target of about 598p according to Simply Wall St.

Galliford Try had also continued to expand its order pipeline, having recently secured positions on all seven lots of a £3bn affordable homes framework with the Hyde Group.

The five-year programme would deliver about 1,500 homes annually across London, the South and East of England - a move chief executive Bill Hocking said aligned with the company's Sustainable Growth Strategy to 2030.

Reporting by Josh White for Sharecast.com.

Top Director Buys

Smith & Nephew (SN.)
Director name: Kong,Garheng
Amount purchased: 3,000 @ $33.98
Value: $84,053.68

Central Asia Metals (CAML)
Director name: Ferrar,Gavin
Amount purchased: 12,669 @ 157.82p
Value: £19,993.96

Avon Technologies (AVON)
Director name: Cashin,Rich
Amount purchased: 8 @ 1,904.00p
Value: £152.32

Avon Technologies (AVON)
Director name: Sclater,Jos
Amount purchased: 8 @ 1,904.00p
Value: £152.32

(ITH)
Director name: Lewis,Iain Clifford Scobbie
Amount purchased: 66 @ 228.00p
Value: £150.48

(ITH)
Director name: Friedman ,Yaniv
Amount purchased: 66 @ 228.00p
Value: £150.48

(ITH)
Director name: Vasques ,Luciano
Amount purchased: 65 @ 228.00p
Value: £148.20



Top Director Sells

Bank Of Ireland Group (cdi) (BIRG)
Director name: O'Grady,Myles
Amount sold: 5,118 @ 14.46
Value: 74,026.24

Bank Of Ireland Group (cdi) (BIRG)
Director name: Spain ,Mark
Amount sold: 3,232 @ 14.46
Value: 46,747.32

Galliford Try (GFRD)
Director name: Hampson ,Kris
Amount sold: 4,474 @ 376.70p
Value: £16,853.56

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Smith and Nephew Market Data

Currency UK Pounds
Share Price 1,236.00p
Change Today -9.00p
% Change -0.72 %
52 Week High 1,435.00p
52 Week Low 937.80p
Volume 226,978
Shares Issued 848.71m
Market Cap £10,490m
RiskGrade 173

Smith and Nephew Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
94.08% below the market average94.08% below the market average94.08% below the market average94.08% below the market average94.08% below the market average
69.7% below the sector average69.7% below the sector average69.7% below the sector average69.7% below the sector average69.7% below the sector average
Price Trend
73.48% above the market average73.48% above the market average73.48% above the market average73.48% above the market average73.48% above the market average
88.57% above the sector average88.57% above the sector average88.57% above the sector average88.57% above the sector average88.57% above the sector average
Income
73.18% below the market average73.18% below the market average73.18% below the market average73.18% below the market average73.18% below the market average
Sector averageSector averageSector averageSector averageSector average
Growth
13.31% above the market average13.31% above the market average13.31% above the market average13.31% above the market average13.31% above the market average
71.43% below the sector average71.43% below the sector average71.43% below the sector average71.43% below the sector average71.43% below the sector average

What The Brokers Say

Strong Buy 4
Buy 3
Neutral 9
Sell 0
Strong Sell 0
Total 16
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Smith and Nephew Dividends

  Latest Previous
  Interim Final
Ex-Div 02-Oct-25 27-Mar-25
Paid 07-Nov-25 28-May-25
Amount 15.00¢ 23.10¢

Trades for 18-Nov-2025

Time Volume / Share Price
12:26 36 @ 1,236.00p
12:25 5 @ 1,235.50p
12:25 184 @ 1,236.50p
12:25 527 @ 1,236.50p
12:23 1 @ 1,237.00p

Smith and Nephew Key Personnel

CEO Deepak Nath
CFO John Rogers

Top of Page